Saturday, April 10, 2021
HomeCOVID-19Today’s talking point

Today’s talking point

-

YESTERDAY’S Mail reported that the Oxford University/AstraZeneca Covid vaccine ’causes twice as many side-effects as a single shot of the Pfizer jab’.

An analysis of 700,000 Brits tracked by King’s College London found that 30 per cent given the UK vaccine suffered mild symptoms including headaches, fatigue or fever compared with about 15 per cent of who reported such side-effects after the Pfizer jab. 

Reports from the Medicines and Healthcare Products Regulatory Agency (MHRA), which have been available for some weeks, of adverse reactions and deaths show a similar disparity.https://www.gov.uk/government/publications/coronavirus-covid-19-vaccine-adverse-reactions/coronavirus-vaccine-summary-of-yellow-card-reporting

As of February 21, after an estimated 9.4million first doses of the Pfizer/BioNTech vaccine had been administered, the MHRA reported 29,715 Yellow Cards notifying reactions; after an estimated 8.4million doses of the Oxford University/AstraZeneca vaccine, there were 42,917 Yellow Cards.

At that date the MHRA had also received 197 UK reports of suspected adverse drug reactions (ADRs) to the Pfizer/BioNTech vaccine in which the patient died shortly after vaccination, compared with 205 reports for the Oxford University/AstraZeneca vaccine and four where the brand of vaccine was unspecified. 

According to Pfizer’s own website, their safety trials are not due to be completed for another two years: ‘The Phase 3 clinical trial of BNT162b2 began on July 27 and has enrolled 43,661 participants to date, 41,135 of whom have received a second dose of the vaccine candidate as of November 13, 2020 . . . The trial will continue to collect efficacy and safety data in participants for an additional two years.’ 

AstraZeneca have boasted that their vaccine is safe and effective at preventing Covid-19, with no severe cases and no hospitalisations, more than 22 days after the first dose. Their safety trials continue for one year after vaccination. 

Do the ADR reports suggest that such confidence may be premature? And given that safety trials of both vaccines are incomplete, are there still too many unknowns for them to pass the test for the type of national vaccination programme that the Johnson Government has instituted?

Feel free to discuss this or anything else on your mind.

- Advertisement -

If you appreciated this article, perhaps you might consider making a donation to The Conservative Woman. Unlike most other websites, we receive no independent funding. Our editors are unpaid and work entirely voluntarily as do the majority of our contributors but there are inevitable costs associated with running a website. We receive no independent funding and depend on our readers to help us, either with regular or one-off payments. You can donate here. Thank you.

Kathy Gyngellhttps://www.conservativewoman.co.uk/the-editors/
Kathy is Editor of The Conservative Woman. She is @KathyConWom on Twitter.

Sign up for The ConWom News

Each morning we send The ConWom Daily with links to our latest news. This is a free service and we will never share your details.